Upgrade to SI Premium - Free Trial

Costa-a (ATX)

21.49 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Amplia Therapeutics Launches First Stage of Registration-Enabling Trial of Narmafotinib May 19, 2026 8:45 AM - Globe NewsWire OTC Markets Group Welcomes ATEX Resources Inc. to OTCQX May 12, 2026 7:00 AM - Globe NewsWire Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study May 8, 2026 8:45 PM - Globe NewsWire Accent Trial Mature Data Presented at International Conference April 22, 2026 8:45 AM - Globe NewsWire The Supply Gap No One's Talking About Is Repricing Copper Developers April 16, 2026 11:30 AM - Globe NewsWire Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial March 24, 2026 9:50 AM - Globe NewsWire Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th March 10, 2026 10:21 AM - Globe NewsWire Full Article List